1. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B;Blatt;Invest. Ophthalmol. Vis. Sci.,1993
2. A murine model of herpes simplex virus-induced ocular disease for antiviral drug testing;Brandt;J. Virol. Method.,1992
3. Ocular herpes simplex virus reactivation in mice latently infected with latency associated transcript mutants;Cook;Invest. Ophthalmol. Vis. Sci.,1991
4. 9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice;Gebhardt;Antiviral Res.,1996
5. Transmission of the virus of herpes febrilis along nerves in experimentally infected rabbits;Goodpasture;J. Med. Res.,1923